newsfilter
← Latest News
Business Wire·

Simulations Plus to Participate in Upcoming Investor Conferences

Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus", "SLP"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that Shawn O'Connor, Chief